Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

BACKGROUND AND PURPOSE: Pancreatic cancer is a highly aggressive malignancy, and improvement in systemic therapy is necessary to treat this frequently encountered metastatic disease. The current targeted agents used in combination with gemcitabine improved objective response rates, but with little o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Iwanski, Gabriela B, Lee, Dhong H, En-Gal, Shlomit, Doan, Ngan B, Castor, Brandon, Vogt, Marco, Toh, Melvin, Bokemeyer, Carsten, Said, Jonathan W, Thoennissen, Nils H, Koeffler, H Phillip
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2010
Schlagworte:
Research Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2936004/
https://ncbi.nlm.nih.gov/pubmed/20590594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2010.00741.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge